EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/17/2026
Back to search
Official data from USPTO
ALLERGAN EYECUE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
07/17/2026
Classification
Registered
Trademark type
Combined
Nice classes
35
Filing date
08/30/2017
Registration date
04/09/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/27/2025
Last transaction
07/17/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/24/2017
First use in commerce
10/24/2017
Drawing code
3
Owner type
03
Owner location
North Chicago, IL, US
Examiner
AGREDA, SAMANTHA LEIGH
Current location
Historical data usage
Mark description
The mark consists of the stylized word "EYECUE" with a stylized eye centered within the space between the upper and lower curved portions of the letter "C". Above the "EYE" portion of "EYECUE" is the stylized word "ALLERGAN".
Holders and representatives
Holders
Allergan, Inc.
Allergan, Inc.
Representatives
Maryam S. Arastu AbbVie Inc.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Operation of telephone call centers for healthcare professionals in the field of eye care products; customer servicesresponding to customers inquiries for health care professionals in the field of eye care products via telephone or other electronic means
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/27/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/27/2025
E815
TEAS SECTION 8 & 15 RECEIVED
10/23/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/05/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/04/2019
DOCK
ASSIGNED TO EXAMINER
02/11/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/31/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/31/2019
IUAF
USE AMENDMENT FILED
01/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2019
EISU
TEAS STATEMENT OF USE RECEIVED
01/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/25/2018
EX1G
SOU EXTENSION 1 GRANTED
07/23/2018
EXT1
SOU EXTENSION 1 FILED
07/23/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/23/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2018
PUBO
PUBLISHED FOR OPPOSITION
01/16/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2017
DOCK
ASSIGNED TO EXAMINER
12/05/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2017
NWAP
NEW APPLICATION ENTERED
09/02/2017
Continuous trademark protection
Get notified about every new filing that threatens ALLERGAN EYECUE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.